User Fee Cover Sheet

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form 3397 User Fee Cover Sheet; Form FDA 3397	Form	Modified	Available
0297CoverMemo.doc	Supplementary Document	Uploaded 2006-08-22	Available
0297-ss2006.doc	Supporting Statement A	Uploaded 2006-08-21	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
5861	User Fee Cover Sheet; Form FDA 3397	Form	Modified

ICR Details

OMB Control No: 0910-0297	ICR Reference No: 200612-0910-002
Status: Historical Active	Previous ICR Reference No: 200310-0910-008
Agency/Subagency: HHS/FDA	Agency Tracking No:
Title: User Fee Cover Sheet
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 01/29/2007
	Date Received in OIRA: 12/13/2006
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2010	36 Months From Approved	01/31/2007
Responses	3,762	0	3,231
Time Burden (Hours)	1,129	0	969
Cost Burden (Dollars)	0	0	0

---

Abstract: The PDUFA of 1992 as amended by FDAMA 1997 and the PHS and Bioterrorism Preparedness and Response Act of 2002 which includes the Prescription Drug User Fee Amendments of 2002 reauthorizes the assessment and use of fees relating to human drugs and licensed biologic products. Form FDA 3397 is used to account for and track user fees reauthorized by PDUFA 1992/FDAMA 1997/FDUFA 2002. The form requests the minimum information necessary to determine whether a fee is required for review of human drug or licensed biologic product applications and supplements. Respodents are manufacturers of human drug and licensed biologic products.

---

Authorizing Statute(s): US Code: 21 USC 379 Name of Law: Federal Food Drug and Cosmetic Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	71 FR 30144	05/25/2006
30-day Notice:	Federal Register Citation:	Citation Date:
	71 FR 51195	08/29/2006
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
User Fee Cover Sheet; Form FDA 3397	3397	Prescription Drug User Fee Coversheet

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	3,762	3,231	0	531	0	0
Annual Time Burden (Hours)	1,129	969	0	160	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The estimated total annual burden for this information collection requirement was 969 hours in 2003. The current increase to 1,129 burden hours is attributed to the increased number of resjpondents and total annual responses received.

---

Annual Cost to Federal Government: $62

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 12/01/2006

---